Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mild Encephalopathy in the Newborn Treated With Darbepoetin (MEND)

NCT03071861 is registered in ClinicalTrials.gov with University of New Mexico as lead sponsor.

NCT NCT03071861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03071861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mild Encephalopathy in the Newborn Treated With Darbepoetin (MEND)
Lead sponsor
University of New Mexico
Phase
Phase 2
Overall status
Completed
Start date
December 1, 2017
Completion date
September 1, 2022
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxic-ischemic encephalopathy mild, neonatal encephalopathy